Clinical Trial Update: The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of combining thermal ablation with Apatinib and Carilimub for advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• Carilimub (carilimub)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN